Saizen usage should be performed under the regular guidance of a physician who is experienced in the diagnosis and management of growth disorders. Children with inadequate secretion of growth hormone sometimes experience fasting hypoglycemia that is improved by treatment with growth hormone. Using Saizen may decrease glucose tolerance. Because human growth hormone may induce a state of insulin resistance, patients should be observed for evidence of glucose intolerance. As with human growth hormone, Saizen should be used with caution in patients with diabetes mellitus or a family history of diabetes mellitus.
HCG (Human chorionic gonadotropin) powder is visually identical to HGH lyophilic powder, and must be reconstituted the same way using bacteriostatic or sterile water. If overused, HCG can be a very dangerous substance. About 42% of North American black market HGH confiscated are fakes.
The majority of fake HGH can be identified by colored top (mostly blue top) vials, with printed ink that can be easily wiped off from the label. The text on the labels is usually in the Spanish language. Another way to test your vial is to rigorously shake it. The actual manufacturers of HGH (rDNA) such as Merck-EMD Serono & Eli Lilly, strongly state in their pamphlets, that their reconstituted vials can easily become cloudy if shaken too rigorously. The reason being is that HGH is a protein and Serono and Eli Lilly warn against injecting the cloudy substance. So if your vial does not become cloudy or stays cloudy after a violent shake, then you know you’ve been scammed.
Protolytic equilibrium in lyophilic nanosized dispersions: Fifferentiating influence of the pseudophase and salt effects.(Report)
Jul 01, 2008; Abstract: The so-called apparent ionization constants of various acids (mainly indicator dyes) in versatile organized solutions...
US Patent Issued to Dai Nippon Printing , Riken on May 10 for "Method for Manufacturing Organic Transistor and Organic Transistor" (Japanese Inventors)
May 13, 2011; ALEXANDRIA, Va., May 13 -- United States Patent no. 7,939,453, issued on May 10, was assigned to Dai Nippon Printing Co. Ltd....